Peregrine Capital Management LLC Cardiovascular Systems Inc Transaction History

Peregrine Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$32.83 - $43.0 $11.7 Million - $15.3 Million	-355,728 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$34.41 - $44.03 $653,583 - $836,305	-18,994 Reduced 5.07%	355,728 $15.2 Million
Q1 2021 May 11, 2021	BUY	$37.29 - $47.19 $194,392 - $246,001	5,213 Added 1.41%	374,722 $14.4 Million
Q4 2020 Jan 19, 2021	SELL	$34.3 - $44.09 $3.1 Million - $3.98 Million	-90,275 Reduced 19.63%	369,509 $16.2 Million
Q3 2020 Oct 20, 2020	SELL	$27.86 - $39.35 $1.22 Million - $1.73 Million	-43,864 Reduced 8.71%	459,784 $18.1 Million
Q2 2020 Jul 30, 2020	BUY	$30.3 - $42.55 $4.84 Million - $6.79 Million	159,588 Added 46.38%	503,648 $15.9 Million
Q1 2020 Apr 17, 2020	BUY	$30.0 - $54.18 $10.3 Million - $18.6 Million	344,060 New	344,060 $12.1 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.